bibliographicCitation |
Intragumtornchai T, Bunworasate U, Nakorn TN, Rojnuckarin P. Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's lymphoma. Leuk Lymphoma. 2006 Jul;47(7):1306–14. doi: 10.1080/10428190500525656. PMID: 16923561. |